Krka, d. d. (KRK.WA)
PLN 590.0
(0.0%)
PLN 590.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 10.14 EUR | -13.26% |
| 2022 | 11.69 EUR | 17.84% |
| 2021 | 9.92 EUR | 7.01% |
| 2020 | 9.27 EUR | 19.92% |
| 2019 | 7.73 EUR | 41.58% |
| 2018 | 5.46 EUR | 15.19% |
| 2017 | 4.74 EUR | 41.49% |
| 2016 | 3.35 EUR | -31.07% |
| 2015 | 4.86 EUR | -4.14% |
| 2014 | 5.07 EUR | -3.24% |
| 2013 | 5.24 EUR | 9.17% |
| 2012 | 4.80 EUR | -1.03% |
| 2011 | 4.85 EUR | -4.15% |
| 2010 | 5.06 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 3.99 EUR | 24.3% |
| 2024 Q1 | 3.21 EUR | 26.38% |
| 2023 Q3 | 2.11 EUR | -19.47% |
| 2023 Q4 | 2.54 EUR | 20.38% |
| 2023 FY | - EUR | -13.26% |
| 2023 Q1 | 2.87 EUR | 42.79% |
| 2023 Q2 | 2.62 EUR | -8.71% |
| 2022 Q1 | 2.91 EUR | 32.88% |
| 2022 Q2 | 4.68 EUR | 60.82% |
| 2022 Q3 | 2.10 EUR | -55.13% |
| 2022 Q4 | 2.01 EUR | -4.29% |
| 2022 FY | - EUR | 17.84% |
| 2021 Q2 | 2.95 EUR | 6.5% |
| 2021 FY | - EUR | 7.01% |
| 2021 Q3 | 2.02 EUR | -31.53% |
| 2021 Q4 | 2.19 EUR | 8.42% |
| 2021 Q1 | 2.77 EUR | 9.06% |
| 2020 Q4 | 2.54 EUR | 57.76% |
| 2020 Q2 | 2.42 EUR | -11.03% |
| 2020 Q1 | 2.72 EUR | 17.24% |
| 2020 FY | - EUR | 19.92% |
| 2020 Q3 | 1.61 EUR | -33.47% |
| 2019 Q3 | 1.03 EUR | -53.39% |
| 2019 Q4 | 2.32 EUR | 125.24% |
| 2019 Q2 | 2.21 EUR | -1.34% |
| 2019 Q1 | 2.24 EUR | 30.99% |
| 2019 FY | - EUR | 41.58% |
| 2018 Q3 | 0.61 EUR | -63.25% |
| 2018 FY | - EUR | 15.19% |
| 2018 Q2 | 1.66 EUR | 7.79% |
| 2018 Q1 | 1.54 EUR | 16.67% |
| 2018 Q4 | 1.71 EUR | 180.33% |
| 2017 Q3 | 0.57 EUR | -62.5% |
| 2017 Q2 | 1.52 EUR | 15.15% |
| 2017 Q1 | 1.32 EUR | 51.72% |
| 2017 Q4 | 1.32 EUR | 131.58% |
| 2017 FY | - EUR | 41.49% |
| 2016 Q2 | 0.92 EUR | -25.81% |
| 2016 FY | - EUR | -31.07% |
| 2016 Q1 | 1.24 EUR | 61.04% |
| 2016 Q4 | 0.87 EUR | 171.88% |
| 2016 Q3 | 0.32 EUR | -65.22% |
| 2015 Q1 | 1.69 EUR | 42.02% |
| 2015 Q2 | 1.77 EUR | 4.73% |
| 2015 FY | - EUR | -4.14% |
| 2015 Q4 | 0.77 EUR | 18.46% |
| 2015 Q3 | 0.65 EUR | -63.28% |
| 2014 FY | - EUR | -3.24% |
| 2014 Q2 | 1.96 EUR | 50.77% |
| 2014 Q4 | 1.19 EUR | 85.94% |
| 2014 Q3 | 0.64 EUR | -67.35% |
| 2014 Q1 | 1.30 EUR | -11.56% |
| 2013 Q3 | 0.75 EUR | -50.0% |
| 2013 Q4 | 1.47 EUR | 96.0% |
| 2013 FY | - EUR | 9.17% |
| 2013 Q1 | 1.55 EUR | 6.16% |
| 2013 Q2 | 1.50 EUR | -3.23% |
| 2012 Q4 | 1.46 EUR | 124.62% |
| 2012 Q2 | 1.25 EUR | -14.38% |
| 2012 Q1 | 1.46 EUR | 2.82% |
| 2012 FY | - EUR | -1.03% |
| 2012 Q3 | 0.65 EUR | -48.0% |
| 2011 FY | - EUR | -4.15% |
| 2011 Q4 | 1.42 EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Celon Pharma S.A. | -0.55 PLN | 1943.636% |